Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals, Inc. (ARMP) Total Non-Current Liabilities (2016 - 2018)

Armata Pharmaceuticals' Total Non-Current Liabilities history spans 6 years, with the latest figure at $3.6 million for Q3 2018.

  • For Q3 2018, Total Non-Current Liabilities changed 0.33% year-over-year to $3.6 million; the TTM value through Sep 2018 reached $3.6 million, changed 0.33%, while the annual FY2017 figure was $3.1 million, 47.97% down from the prior year.
  • Total Non-Current Liabilities for Q3 2018 was $3.6 million at Armata Pharmaceuticals, up from $3.2 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $69.5 million in Q1 2014 and bottomed at $2.9 million in Q1 2018.
  • The 5-year median for Total Non-Current Liabilities is $6.1 million (2016), against an average of $14.2 million.
  • The largest annual shift saw Total Non-Current Liabilities plummeted 71.41% in 2014 before it fell 0.33% in 2018.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $17.4 million in 2014, then tumbled by 57.01% to $7.5 million in 2015, then dropped by 19.79% to $6.0 million in 2016, then tumbled by 47.97% to $3.1 million in 2017, then grew by 15.96% to $3.6 million in 2018.
  • Per Business Quant, the three most recent readings for ARMP's Total Non-Current Liabilities are $3.6 million (Q3 2018), $3.2 million (Q2 2018), and $2.9 million (Q1 2018).